Apoptosis induced by paclitaxel via Bcl-2, Bax and caspases 3 and 9 activation in NB4 human leukaemia cells is not modulated by ERK inhibition

Experimental and Toxicologic Pathology

Volumn 65, Issue 7-8, 2013, Pages 1101-1108

  Morales Cano, Daniel ^a   Calviño, Eva ^a   Rubio, Virginia ^a   Herráez, Angel ^a   Sancho, Pilar ^a   Tejedor, M Cristina ^a   Diez, José C ^a  

^a UNIVERSITY OF ALCALÁ   (Spain)

Author keywords

Apoptosis; Bax; Bcl 2; Caspases; Kinases; Leukaemia; P53

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; CASPASE 3; CASPASE 9; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; PACLITAXEL; PROTEIN BAX; PROTEIN BCL 2; PROTEIN P53;

APOPTOSIS; ARTICLE; CELL VIABILITY; CONTROLLED STUDY; DNA FRAGMENTATION; HUMAN; HUMAN CELL; LEUKEMIA CELL; PROMYELOCYTIC LEUKEMIA; PROTEIN PHOSPHORYLATION;

APOPTOSIS; BAX; BCL-2; CASPASES; KINASES; LEUKAEMIA; P53;

ANTINEOPLASTIC AGENTS; APOPTOSIS; BCL-2-ASSOCIATED X PROTEIN; BLOTTING, WESTERN; CASPASE 3; CASPASE 9; CELL LINE, TUMOR; CELL SURVIVAL; ENZYME ACTIVATION; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; FLOW CYTOMETRY; HUMANS; LEUKEMIA; PACLITAXEL; PROTO-ONCOGENE PROTEINS C-BCL-2; SIGNAL TRANSDUCTION;

EID: 84885870263     PISSN: 09402993     EISSN: 16181433     Source Type: Journal    
DOI: 10.1016/j.etp.2013.04.006     Document Type: Article

References (46)

1. Abrams S.L., Steelman L.S., Shelton J.G., Chappell W., Bäsecke J., Stivala F., et al. Enhancing therapeutic efficacy by targeting non-oncogene addicted cells with combinations of signal transduction inhibitors and chemotherapy. Cell Cycle 2010, 9:1839-1846.
2. Bacus S.S., Gudkov A.V., Lowe M., Lyass L., Yung Y., Komarov A.P., et al. Taxol-induced apoptosis depends on MAP kinase pathways (ERK and p38) and is independent of p53. Oncogene 2001, 20(2):147-155.
3. Bergstralh D.T., Ting J.P. Microtubule stabilizing agents: their molecular signaling consequences and the potential for enhancement by drug combination. Cancer Treatment Reviews 2006, 32(3):166-179.
4. Cagnol S., Chambard J.-C. ERK and cell death: mechanisms of ERK-induced cell death-apoptosis, autophagy and senescence. FEBS Journal 2010, 277(1):2-21.
5. Cincinelli R., Dallavalle S., Nannei R., Carella S., De Zani D., Merlini L., et al. Synthesis and structure-activity relationships of a new series of retinoid-related biphenyl-r-ylacrylic acids endowed with antiproliferative and proapoptotic activity. Journal of Medicinal Chemistry 2005, 48:4931-4946.
6. Chrysomali E., Nikitakis N.G., Tosios K., Sauk J.J., Papanicolaou S.I. Immunohistochemical evaluation of cell proliferation antigen Ki-67 and apoptosis-related proteins Bcl-2 and caspase-3 in oral granular cell tumor. Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology and Endodontics 2003, 96:566-572.
7. Drexler H.G., Quentmeier H., MacLeod R.A.F., Uphoff C.C., Hu Z.B. Leukaemia cell lines: in vitro models for the study of acute promyelocytic leukaemia. Leukaemia Research 1995, 19:681-691.
8. Ganansia-Leymarie V., Bischoff P., Bergerat J.P., Holl V. Signal transduction pathways of taxanes-induced apoptosis. Current Medicinal Chemistry: Anticancer Agents 2003, 3(4):291-306.
9. George J., Banik N.L., Ray S.K. Bcl-2 siRNA augments taxol mediated apoptotic death in human glioblastoma U138MG and U251MG cells. Neurochemical Research 2008, 34(19):66-78.
10. Lanotte M., Martin-Thouvenin V., Najman S., Balerini P., Valensi F., Berger R. NB4, a maturation inducible cell line with t(15;17) marker isolated from a human acute promyelocytic leukaemia (M3). Blood 1991, 77:1080-1086.
11. Lee J.T., McCubrey J.A. The Raf/MEK/ERK signal transduction cascade as a target for chemotherapeutic intervention in leukaemia. Leukaemia 2002, 16(4):486-507.
12. Lee S.H., Park S.W., Pyo C.W., Yoo N.K., Kim J., Choi S.Y. Requirement of the JNK-associated Bcl-2 pathway for human lactoferrin-induced apoptosis in the Jurkat leukaemia T cell line. Biochimie 2009, 91(1):102-108.
13. Liao P.C., Lieu C.H. Cell cycle specific induction of apoptosis and necrosis by paclitaxel in the leukemic U937 cells. Life Sciences 2005, 76(14):1623-1639.
14. Lo-Coco F., Ammatuna E., Montesinos P., Sanz M.A. Acute promyelocytic leukaemia: recent advances in diagnosis and management. Seminars in Oncology 2008, 35:401-409.
15. Lu K.H., Lue K.H., Liao H.H., Lin K.L., Chung J.G. Induction of caspase-3-dependent apoptosis in human leukaemia HL-60 cells by paclitaxel. Clinica Chimica Acta 2005, 357(1):65-73.
16. Maksumova L., Ohnishi K., Muratkhodjaev F., Zhang W., Pan L., Takeshita A., et al. Increased sensitivity of multidrug-resistant myeloid leukaemia cell lines to lovastatin. Leukaemia 2000, 14:1444-1450.
17. McCubrey J.A., Steelman L.S., Chappell W.H., Abrams S.L., Wong E.W., Chang F., et al. Roles of the Raf/MEK/ERK pathway in cell growth, malignant transformation and drug resistance. Biochimica et Biophysica Acta 2007, 1773(8):1263-1284.
18. Melnick A., Licht J.C. Decontruction a desease: RARalpha, its fusion partners, and their roles in the pathogenesis of acute promyelocytic leukaemia. Blood 1999, 93:3167-3215.
19. Nishioka C., Ikezoe T., Yang J., Yokoyama A. Inhibition of MEK/ERK signaling induces apoptosis of acute myelogenous leukaemia cells via inhibition of eukaryotic initiation factor 4E-binding protein 1 and down-regulation of Mcl-1. Apoptosis 2010, 15(7):795-804.
20. Oh S.Y., Song J.H., Gil J.E., Kim J.H., Yeom Y.I., Moon E.Y. ERK activation by thymosin-beta-4 (TB4) overexpression induces paclitaxel-resistance. Experimental Cell Research 2006, 312(9):1651-1657.
21. Park S.J., Wu C.H., Gordon J.D., Zhong X., Emami A., Safa A.R. Taxol induces caspase-10-dependent apoptosis. Journal of Biological Chemistry 2004, 279(49):51057-51067.
22. Pellegrini F., Budman D.R. Review: tubulin function, action of antitubulin drugs, and new drug development. Cancer Investigation 2005, 23(3):264-273.
23. Pushkarev V.M., Starenki D.V., Saenko V.A., Namba H., Kurebayashi J., Tronko M.D., et al. Molecular mechanisms of the effects of low concentrations of taxol in anaplastic thyroid cancer cells. Endocrinology 2004, 145(7):3143-3152.
24. Qiu L., Zhou C., Sun Y., Di W., Scheffler E., Healey S., et al. Paclitaxel and ceramide synergistically induce cell death with transient activation of EGFR and ERK pathway in pancreatic cancer cells. Oncology Reports 2006, 16(4):907-913.
25. Ramos A.M., Fernández C., Amrán D., Sancho P., de Blas E., Aller P. Pharmacologic inhibitors of PI3K/Akt potentiate the apoptotic action of the antileukemic drug arsenic trioxide via glutahione depletion and increased peroxide accumulation in myeloid leukaemia cells. Blood 2005, 105:4013-4020.
26. Roussel M.J.S., Lanotte M. Maturacion sensitive and resistant t(15;17) NB4 cell lines as tool for APL physiopathology: nomenclature of cells and repertory of their known genetic alteration and phenoypes. Oncogene 2001, 20:7287-7291.
27. Rowley J.D., Golomb H.M., Vardiman J., Fukuhara S., Dougherty C., Potter D. Furter evidence for a non-random chromosomal abnormality in acute promyelocytic leukaemia. International Journal of Cancer 1977, 20:869-872.
28. Santos-Silva M.C., Sampaio de Freitas M., Assreuy J. Killing of lymphoblastic leukaemia cells by nitric oxide and taxol: involvement of NF-kappaB activity. Cancer Letters 2001, 173(1):53-61.
29. Santos-Silva M.C., Freitas M.S., Assreuy J. Involvement of NF-kappaB and glutathione in cytotoxic effects of nitric oxide and taxol on human leukaemia cells. Leukaemia Research 2006, 30(2):145-152.
30. Selimovic D., Hassan M., Haikel Y., Hengge U.R. Taxol-induced mitochondrial stress in melanoma cells is mediated by activation of c-Jun N-terminal kinase (JNK) and p38 pathways via uncoupling protein 2. Cellular Signalling 2008, 20(2):311-322.
31. Sen S., Sharma H., Singh N. Curcumin enhances vinorelbine mediated apoptosis in NSCLC cells by the mitochondrial pathway. Biochemical and Biophysical Research Communications 2005, 331(4):1245-1252.
32. Stadheim T.A., Xiao H., Eastman A. Inhibition of extracellular signal-regulated kinase (ERK) mediates cell cycle phase independent apoptosis in vinblastine-treated ML-1 cells. Cancer Research 2001, 61(4):1533-1540.
33. Steelman L.S., Abrams S.L., Whelan J., Bertrand F.E., Ludwig D.E., Bäsecke J., et al. Contributions of the Raf/MEK/ERK, PI3K/PTEN/Akt/mTOR and Jak/STAT pathways to leukaemia. Leukaemia 2008, 22(4):686-707.
34. Shimizu S., Tsujimoto Y. Proapoptotic BH3-only Bcl-2 family members induce cytochrome c release, but not mitochondrial membrane potential loss, and do not directly modulate voltage-dependent anion channel activity. Proceedings of the National Academy of Sciences of the United States of America 2000, 97(2):577-582.
35. Song G., Ouyang G., Bao S. The activation of Akt/PKB signaling pathway and cell survival. Journal of Cellular and Molecular Medicine 2005, 9(1):59-71.
36. Vrana J.A., Cleaveland E.S., Eastman A., Craig R.W. Inducer-and cell type-specific regulation of antiapoptotic MCL1 in myeloid leukaemia and multiple myeloma cells exposed to differentiation-inducing or microtubule-disrupting agents. Apoptosis 2006, 11(8):1275-1288.
37. Wan Y.F., Guo X.Q., Wang Z.H., Ying K., Yao M.H. Effects of paclitaxel on proliferation and apoptosis in human acute myeloid leukaemia HL-60 cells. Acta Pharmacologica Sinica 2004, 25(3):378-384.
38. Wang T.H., Wang H.S., Soong Y.K. Paclitaxel-induced cell death: where the cell cycle and apoptosis come together. Cancer 2000, 88(11):2619-2628.
39. Xu R., Sato N., Yanai K., Akiyoshi T., Nagai S., Akiyoshi T., et al. Enhancement of paclitaxel-induced apoptosis by inhibition of mitogen-activated protein kinase pathway in colon cancer cells. Anticancer Research 2009, 29:261-270.
40. Xu Y., Liu L., Qiu X., Liu Z., Li H., Li Z., et al. CCL21/CCR7 prevents apoptosis via the ERK pathway in human nonsmall cell lung cancer cells. PLoS ONE 2012, 7(3):e33262. Epub 2012 March 16.
41. Xu R., Sato N., Yanai K., Akiyoshi T., Nagai S., Wada J., et al. Enhancement of paclitaxel-induced apoptosis by inhibition of mitogen-activated protein kinase pathway in colon cancer cells. Anticancer Research 2009, 29:261-270.
42. Yu C., Wang S., Dent P., Grant S. Sequence-dependent potentiation of paclitaxel-mediated apoptosis in human leukaemia cells by inhibitors of the mitogen-activated protein kinase kinase/mitogen-activated protein kinase pathway. Molecular Pharmacology 2001, 60(1):143-154.
43. Zhang W., Zhao L., Liu J., Du J., Wang Z., Ruan C., et al. Cisplatin induces platelet apoptosis through the ERK signaling pathway. Thrombosis Research 2012, 130(1):81-91.
44. Zhuang S., Schnellmann R.G. A death-promoting role for extracellular signal-regulated kinase. Journal of Pharmacology and Experimental Therapeutics 2006, 319(3):991-997.
45. Zhou X., Xu L., He K., Zhang T., Zhu W., Li X., et al. Taxol-induced apoptosis in Jurkat T cell lymphoma cell line and its molecular mechanisms. Zhonghua Xue Ye Xue Za Zhi 2000, 21(6):298-300.
46. Zou H., Henzel W.J., Liu X., Lutschg A., Wang X. Apaf-1, a human protein homologous to C. elegans CED-4, participates in cytochrome c-dependent activation of caspase-3. Cell 1997, 90(3):405-413.